Literature DB >> 423136

Sensitive high-pressure liquid chromatographic determination of propranolol in plasma.

G Nygard, W H Shelver, S K Wahba Khalil.   

Abstract

A high-pressure liquid chromatographic method is presented for the determination of propranolol in human plasma. A reversed-phase cyanopropylsilane column was utilized with a liquid phase consisting of 70% acetonitrile and 30% 0.02 M acetate buffer, pH 7.0. A spectrofluorometric detector with an excitation wavelength of 276 nm and an emission filter with a 340-nm cutoff provided a detectable peak for 0.8 ng of propranolol/injection with this system. The reproducibility and precision of the method are shown from the analyses of samples containing 10--150 ng/ml of plasma.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 423136     DOI: 10.1002/jps.2600680336

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  7 in total

1.  Effect of exercise on propranolol pharmacokinetics.

Authors:  S Frank; S M Somani; M Kohnle
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

2.  Comparison of changes in the characteristics of beta-adrenoceptors and responsiveness of human circulating lymphocytes during and after chronic administration of pindolol and propranolol.

Authors:  Y Giudicelli; D Lacasa; B Agli; A Leneveu
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

3.  Relationship between dose, blood level and haemodynamic response in patients with cirrhosis receiving propranolol.

Authors:  M I Jirón; B Delhotal; D Lebrec
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

4.  A standard approach to compiling clinical pharmacokinetic data.

Authors:  L B Sheiner; L Z Benet; L A Pagliaro
Journal:  J Pharmacokinet Biopharm       Date:  1981-02

5.  An improved extraction procedure for the liquid chromatographic determination of propranolol and 4-hydroxypropranolol in plasma.

Authors:  P Gyselinck; J P Remon; R Van Severen; P Braeckman
Journal:  Br J Clin Pharmacol       Date:  1980-10       Impact factor: 4.335

6.  Controlled study of metoprolol and propranolol during prolonged administration in patients with essential tremor.

Authors:  S Calzetti; L J Findley; E Perucca; A Richens
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-10       Impact factor: 10.154

7.  The response of essential tremor to propranolol: evaluation of clinical variables governing its efficacy on prolonged administration.

Authors:  S Calzetti; L J Findley; E Perucca; A Richens
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-05       Impact factor: 10.154

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.